Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal

Area of Science:

• Gynecology
• Surgical Quality Improvement
• Urogynecology

Background:

• Uterine leiomyomata (fibroids) are common benign tumors.
• Hysterectomy is a frequent surgical treatment for symptomatic fibroids.
• Assessing risks associated with hysterectomy for larger uteri is crucial for patient management.

Purpose of the Study:

• To evaluate the correlation between clinical uterine size estimation and actual uterine weight.
• To assess perioperative outcomes and complications in patients undergoing hysterectomy for uterine leiomyomata, stratified by uterine size.
• To determine if larger uteri (≥12 weeks' gestation size) are associated with increased operative morbidity.

Main Methods:

• Retrospective review of 104 consecutive hysterectomy cases for uterine leiomyomata.
• Histological confirmation of diagnosis.
• Stratification of 93 confirmed cases by preoperative uterine size estimate and specimen weight.
• Analysis of intraoperative estimated blood loss and hematocrit changes.
• Comparison of perioperative complications, blood loss, and transfusion rates between larger and smaller uteri.

Main Results:

• Physician's clinical estimate of uterine size correlated well with specimen weight (r=0.65, P<.001).
• Intraoperative blood loss estimation showed a weaker correlation with hematocrit change (r=0.31, P=.03).
• Uteri estimated larger than 12 weeks' gestation were not associated with increased perioperative complications, estimated blood loss, or transfusion rates.

Conclusions:

• Hysterectomy for uterine leiomyomata in uteri sized greater than 12 weeks' gestation does not lead to increased adverse short-term outcomes.
• Prophylactic hysterectomy for asymptomatic women with larger uteri is not routinely recommended to avoid operative morbidity.
• Clinical uterine size estimation is a reliable predictor of specimen weight in leiomyomata cases.